Baby eczema cream may stop food allergies before they start
NCT ID NCT03742414
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a special skin barrier cream (Epiceram) twice a day, along with a steroid cream at the first sign of eczema, can prevent food allergies in babies who develop eczema by 12 weeks old. The goal is to see if this proactive skin care reduces the number of foods the babies become allergic to. The trial enrolled 398 infants and is currently active but no longer recruiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tri-lipid skin barrier cream (Epiceram) and fluticasone propionate cream
What this could lead to
If it works, this could point toward a simple skin care routine that prevents food allergies in babies with eczema.
What could go wrong
This is a Phase 2 trial, so results are still early. The approach may not prevent allergies for all babies, and steroid creams have potential side effects with long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Division of Pediatric Allergy and Clinical Immunology, National Jewish Health
Denver, Colorado, 80206, United States
-
Sean N. Parker Center for Allergy & Asthma Research at Stanford University
Palo Alto, California, 94304, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
• King's College London and Guy's and St. Thomas' NHS Foundation Trust, UK
London, London, United Kingdom